Zróżnicowany obraz funkcjonowania poznawczego chorych ze stwardnieniem rozsianym Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
wrz 30, 2020
Słowa kluczowe:
funkcjonowanie poznawcze, metody oceny, stwardnienie rozsiane
##plugins.themes.bootstrap3.article.main##
Abstrakt
Autorzy przedstawiają trudności metodologiczne w ocenie funkcjonowania poznawczego chorych na stwardnienie rozsiane, stanowiących bardzo zróżnicowaną grupę. Powodują one, że uogólnianie wniosków z badań przedstawianych w piśmiennictwie tematu ma pewne ograniczenia. Czytelnik ma możliwość zapoznania się z różnymi narzędziami pomiaru zdolności poznawczych rekomendowanymi dla tej populacji chorych.
##plugins.themes.bootstrap3.article.details##
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Islas M, Ciampi E. Assessment and Impact of Cognitive Impairment in Multiple Sclerosis: An Overview. Biomedicine. 2019; 7: 22. https://doi.org/10.3390/biomedicines7010022.
2. Murray TJ. Multiple Sclerosis: The History of a Disease. Demos Medical Publishing 2005; 2: 461.
3. Langdon D. Cognitive impairment in multiple sclerosis – recent advances and future prospects. Eur Neurol Rev. 2010; 5(1): 69-72.
4. Sartori E, Edan G. Assessment of cognitive dysfunction in multiple sclerosis. J Neurol Sci. 2006; 245(1): 169-75.
5. Sumowski J, Benedict R, Enzinger C et al. Cognition in multiple sclerosis. State of the field and priorities for the future. Neurology. 2018; 90: 278-88.
6. Clemens L, Langdon D. How does cognition relate to employment in multiple sclerosis? A systematic review. Mult Scler Relat Disord. 2018; 26: 183-91.
7. Figved N, Myhr K-M, Larsen J-P et al. Caregiver burden in multiple sclerosis. The impact of neuropsychiatric symptomps. J Neurol Neurosurg Psychiatry. 2007; 78: 1097-102.
8. Amato M, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci. 2006; 245(1-2): 41-6.
9. Chiaravalloti N, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008; 7: 1139-51.
10. DiGiuseppe G, Blair M, Morrow S. Prevalence of cognitive impairment in newly diagnosed relapsing-remitting multiple sclerosis. Int J MS Care. 2018; 20: 153-7.
11. Johnen A, Landmeyer N, Bürkner P-C et al. Distinct cognitive impairments in different disease courses of multiple sclerosis. A systematic review and meta-analysis. Neurosci Biobehav Rev. 2017, 83: 568-78.
12. Calabrese P. Neuropsychology of multiple sclerosis. An overview. J Neurol. 2006; 253(I): 10-5.
13. Ernst A. Autobiographical memory and future thinking impairments in multiple sclerosis: Cognitive and neural mechanisms, functional impact and rehabilitation. Ann Phys Rehabil Med. 2019 (w druku). https://doi.org/doi.org/10.1016/j.rehab.2019.06.006.
14. Dulau C, Deloire M, Diaz H et al. Social cognition according to cognitive impairment in different clinical phenotypes of multiple sclerosis. J Neurol. 2017; 264(4): 740-8.
15. DiFilippo M, Portaccio E, Mancini A et al. Multiple sclerosis and cognition: Synaptic failure and network dysfunction. Nature Reviews. Neuroscience. 2019; 19: 599-609.
16. Benedict R, Zivadinov R. Reliability and validity of neuropsychological screening and assessment strategies in MS. J Neurol. 2007; 254(S2): II22-II25.
17. Portaccio E. Differential diagnosis, discerning depression from cognition. Acta Neurol Scand. 2016; 134(Suppl. 200): 14-8.
18. Roessler-Górecka M, Iwański S, Seniów J. Wartość pomiaru samoopisowego w diagnostyce neuropsychologicznej pacjentów z uszkodzeniem mózgu. Psychiatr Pol. 2013; 47(3): 465-74.
19. Langdon D, Amato M, Boringa B et al. Recommendation for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler. 2012; 18: 891-8.
20. Rao S. The Cognitive Function Study Group of the National Multiple Sclerosis Society. A manual for brief repeatable battery of the neuropsychological tests in multiple sclerosis. Milwaukee, WI: Medical College of Wisconsin, 1990.
21. Hansen S, Muenssinger J, Kronhofmann S et al. Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao’s Brief Repeatable Battery. BMC Neurol. 2015; 15: 246.
22. Benedict R, Fisher J, Archibald C et al. Minimal Neuropsychological Assessment of MS Patients: a consensus approach. Clin Neuropsychol. 2002; 16: 381-97.
23. Benedict R, Cookfair D, Gavett R et al. Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006; 12(4): 549-58.
24. Benedict R, Munschauer F, Linn R et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler. 2003; 9: 95.
25. Benedict R, Cox D, Thompson L et al. Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler. 2004; 10(6): 675-8.
26. Fischer J, LaRocca N, Miller D et al. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler. 1999; 5(4): 251-9.
27. Strober L, Binder A, Nikelspuhr O et al. The Perceived Deficits Questionnaire. Perception, deficit or distress. Int. J. MS Care. 2016; 18(4): 183-90.
28. Parmenter B, Weinstock-Guttman B, Garg N. Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test. Mult Scler. 2007; 13(1): 52-7.
29. Benedict R, Duquin J, Jurgensen S et al. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler. 2008; 14: 940-6.
30. Meca-Lallana J, Prieto-Gonzalez J, Jimenez-Veiga J et al. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test). Mult Scler Relat Disord. 2019; 28: 50-6.
31. Ruet A, Brochet B. Cognitive assessment in patients with multiple sclerosis: From neuropsychological batteries to ecological tools. Ann Phys Rehabil Med. 2018 (in press). https://doi.org/10.1016/j.rehab.2018.01.006.
2. Murray TJ. Multiple Sclerosis: The History of a Disease. Demos Medical Publishing 2005; 2: 461.
3. Langdon D. Cognitive impairment in multiple sclerosis – recent advances and future prospects. Eur Neurol Rev. 2010; 5(1): 69-72.
4. Sartori E, Edan G. Assessment of cognitive dysfunction in multiple sclerosis. J Neurol Sci. 2006; 245(1): 169-75.
5. Sumowski J, Benedict R, Enzinger C et al. Cognition in multiple sclerosis. State of the field and priorities for the future. Neurology. 2018; 90: 278-88.
6. Clemens L, Langdon D. How does cognition relate to employment in multiple sclerosis? A systematic review. Mult Scler Relat Disord. 2018; 26: 183-91.
7. Figved N, Myhr K-M, Larsen J-P et al. Caregiver burden in multiple sclerosis. The impact of neuropsychiatric symptomps. J Neurol Neurosurg Psychiatry. 2007; 78: 1097-102.
8. Amato M, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci. 2006; 245(1-2): 41-6.
9. Chiaravalloti N, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008; 7: 1139-51.
10. DiGiuseppe G, Blair M, Morrow S. Prevalence of cognitive impairment in newly diagnosed relapsing-remitting multiple sclerosis. Int J MS Care. 2018; 20: 153-7.
11. Johnen A, Landmeyer N, Bürkner P-C et al. Distinct cognitive impairments in different disease courses of multiple sclerosis. A systematic review and meta-analysis. Neurosci Biobehav Rev. 2017, 83: 568-78.
12. Calabrese P. Neuropsychology of multiple sclerosis. An overview. J Neurol. 2006; 253(I): 10-5.
13. Ernst A. Autobiographical memory and future thinking impairments in multiple sclerosis: Cognitive and neural mechanisms, functional impact and rehabilitation. Ann Phys Rehabil Med. 2019 (w druku). https://doi.org/doi.org/10.1016/j.rehab.2019.06.006.
14. Dulau C, Deloire M, Diaz H et al. Social cognition according to cognitive impairment in different clinical phenotypes of multiple sclerosis. J Neurol. 2017; 264(4): 740-8.
15. DiFilippo M, Portaccio E, Mancini A et al. Multiple sclerosis and cognition: Synaptic failure and network dysfunction. Nature Reviews. Neuroscience. 2019; 19: 599-609.
16. Benedict R, Zivadinov R. Reliability and validity of neuropsychological screening and assessment strategies in MS. J Neurol. 2007; 254(S2): II22-II25.
17. Portaccio E. Differential diagnosis, discerning depression from cognition. Acta Neurol Scand. 2016; 134(Suppl. 200): 14-8.
18. Roessler-Górecka M, Iwański S, Seniów J. Wartość pomiaru samoopisowego w diagnostyce neuropsychologicznej pacjentów z uszkodzeniem mózgu. Psychiatr Pol. 2013; 47(3): 465-74.
19. Langdon D, Amato M, Boringa B et al. Recommendation for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler. 2012; 18: 891-8.
20. Rao S. The Cognitive Function Study Group of the National Multiple Sclerosis Society. A manual for brief repeatable battery of the neuropsychological tests in multiple sclerosis. Milwaukee, WI: Medical College of Wisconsin, 1990.
21. Hansen S, Muenssinger J, Kronhofmann S et al. Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao’s Brief Repeatable Battery. BMC Neurol. 2015; 15: 246.
22. Benedict R, Fisher J, Archibald C et al. Minimal Neuropsychological Assessment of MS Patients: a consensus approach. Clin Neuropsychol. 2002; 16: 381-97.
23. Benedict R, Cookfair D, Gavett R et al. Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006; 12(4): 549-58.
24. Benedict R, Munschauer F, Linn R et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler. 2003; 9: 95.
25. Benedict R, Cox D, Thompson L et al. Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler. 2004; 10(6): 675-8.
26. Fischer J, LaRocca N, Miller D et al. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler. 1999; 5(4): 251-9.
27. Strober L, Binder A, Nikelspuhr O et al. The Perceived Deficits Questionnaire. Perception, deficit or distress. Int. J. MS Care. 2016; 18(4): 183-90.
28. Parmenter B, Weinstock-Guttman B, Garg N. Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test. Mult Scler. 2007; 13(1): 52-7.
29. Benedict R, Duquin J, Jurgensen S et al. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler. 2008; 14: 940-6.
30. Meca-Lallana J, Prieto-Gonzalez J, Jimenez-Veiga J et al. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test). Mult Scler Relat Disord. 2019; 28: 50-6.
31. Ruet A, Brochet B. Cognitive assessment in patients with multiple sclerosis: From neuropsychological batteries to ecological tools. Ann Phys Rehabil Med. 2018 (in press). https://doi.org/10.1016/j.rehab.2018.01.006.